Benjamin Herzberg, MD, highlights ASCO 2026's most exciting KRAS data, sequencing strategies, and emerging therapies for KRAS-mutant lung cancer.
Benjamin Herzberg, MD
Advertisement
Benjamin Herzberg, MD, is a thoracic medical oncologist at the Herbert Irving Comprehensive Cancer Center at Columbia University.
Articles by Benjamin Herzberg, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Phase 3 LAGOON Trial Fails to Confirm Survival Benefit of Lurbinectedin in Relapsed SCLC
2
FDA Approves Capivasertib Plus Abiraterone and Prednisone for PTEN-Deficient Prostate Cancer
3
The Gap Between What Oncologists Have Been Prescribing and What the ROS1 Data Now Supports
4
Talquetamab Plus Daratumumab Improves PFS vs SOC in R/R Multiple Myeloma
5